Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
GoGreen Membership

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 13 April 2007:
Vol. 316. no. 5822, pp. 285 - 288
DOI: 10.1126/science.1137221
Prev | Table of Contents | Next

Reports

Lymphotoxin ß Receptor–Dependent Control of Lipid Homeostasis

James C. Lo,1* Yugang Wang,2* Alexei V. Tumanov,2* Michelle Bamji,3 Zemin Yao,3 Catherine A. Reardon,2 Godfrey S. Getz,2{dagger} Yang-Xin Fu1,2{dagger}

Hyperlipidemia, one of the most important risk factors for coronary heart disease, is often associated with inflammation. We identified lymphotoxin (LT) and LIGHT, tumor necrosis factor cytokine family members that are primarily expressed on lymphocytes, as critical regulators of key enzymes that control lipid metabolism. Dysregulation of LIGHT expression on T cells resulted in hypertriglyceridemia and hypercholesterolemia. In low-density lipoprotein receptor–deficient mice, which lack the ability to control lipid levels in the blood, inhibition of LT and LIGHT signaling with a soluble lymphotoxin ß receptor decoy protein attenuated the dyslipidemia. These results suggest that the immune system directly influences lipid metabolism and that LT modulating agents may represent a novel therapeutic route for the treatment of dyslipidemia.

1 Committee on Immunology, University of Chicago, Chicago, IL 60637, USA.
2 Department of Pathology, University of Chicago, Chicago, IL 60637, USA.
3 Department of Biochemistry, Microbiology and Immunology, University of Ottawa Heart Institute, Ottawa, Ontario K1H 8M5, Canada.

* These authors contributed equally to this work.

{dagger} To whom correspondence should be addressed. E-mail: yfu{at}uchicago.edu (Y.-X.F.); getz{at}bsd.uchicago.edu (G.S.G.)

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
CD137 Is Expressed in Human Atherosclerosis and Promotes Development of Plaque Inflammation in Hypercholesterolemic Mice.
P. S. Olofsson, L. A. Soderstrom, D. Wagsater, Y. Sheikine, P. Ocaya, F. Lang, C. Rabu, L. Chen, M. Rudling, P. Aukrust, et al. (2008)
Circulation 117, 1292-1301
   Abstract »    Full Text »    PDF »
Combined Deletion of Macrophage ABCA1 and ABCG1 Leads to Massive Lipid Accumulation in Tissue Macrophages and Distinct Atherosclerosis at Relatively Low Plasma Cholesterol Levels.
R. Out, M. Hoekstra, K. Habets, I. Meurs, V. de Waard, R. B. Hildebrand, Y. Wang, G. Chimini, J. Kuiper, T. J.C. Van Berkel, et al. (2008)
Arterioscler. Thromb. Vasc. Biol. 28, 258-264
   Abstract »    Full Text »    PDF »
Lymphotoxin-{beta} regulates periderm differentiation during embryonic skin development.
C.-Y. Cui, M. Kunisada, D. Esibizione, S. I. Grivennikov, Y. Piao, S. A. Nedospasov, and D. Schlessinger (2007)
Hum. Mol. Genet. 16, 2583-2590
   Abstract »    Full Text »    PDF »
Immunity raises cholesterol.
N. LeBrasseur (2007)
J. Cell Biol. 177, 373a
   Full Text »    PDF »


ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)